Literature DB >> 25795947

Whey and soy protein supplements changes body composition in patients with Crohn's disease undergoing azathioprine and anti-TNF-alpha therapy.

Júlia Figueiredo Machado1, Vanessa Oya2, Cláudio Saddy Rodrigues Coy3, André Moreno Morcillo2, Silvana Dalge Severino2, Chao Wu4, Valdemiro Carlos Sgarbieri5, Maria Marluce dos Santos Vilela2.   

Abstract

BACKGROUND: Crohn's disease (CD) is a chronic transmural inflammation of the gastrointestinal tract of unknown cause. Malnutrition associated with active CD has been reduced although obesity has increased. Dietary strategies such as those with high-protein have been proposed to reduce body fat. This study compares the effects of two supplements on the nutritional status of CD patients.
MATERIALS AND METHODS: 68 CD patients were randomized in two groups: whey protein group (WP) and soy protein group (SP). Using bioimpedance analysis, anthropometry and albumin and pre-albumin dosages the nutritional status was measured before starting the intervention and after 8 and 16 weeks. The disease activity was determined by Crohn's Disease Activity Index and serum C-reactive protein dosage and dietary intake by 24h dietary recalls.
RESULTS: Forty-one patients concluded the study and both supplements changed body composition similarly. Triceps skin fold thickness (p< 0.001) and body fat percentage (p=0.001) decreased, whereas mid-arm muscle circumference (p=0.004), corrected arm muscle area (p=0.005) and body lean percentage (p=0.001) increased.
CONCLUSIONS: For Crohn's disease patients undergoing anti TNF-alpha and azatioprine therapies, supplementation with whey and soy proteins changes body composition through reduction of body fat and thus contributes to control inflammation. Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25795947     DOI: 10.3305/nh.2015.31.4.8362

Source DB:  PubMed          Journal:  Nutr Hosp        ISSN: 0212-1611            Impact factor:   1.057


  3 in total

Review 1.  Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults.

Authors:  Gerda C Leitner; Harald Vogelsang
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

Review 2.  Potential role of nutraceutical compounds in inflammatory bowel disease.

Authors:  Tiziana Larussa; Maria Imeneo; Francesco Luzza
Journal:  World J Gastroenterol       Date:  2017-04-14       Impact factor: 5.742

3.  Dosage of Dual-Protein Nutrition Differentially Impacts the Formation of Atherosclerosis in ApoE-/- Mice.

Authors:  Yingchun Huang; Kun Zhang; Li Zhang; Juhui Qiu; Lin Fu; Tieying Yin; Jing Wang; Rui Qin; Jingjie Zhang; Xianwen Dong; Guixue Wang
Journal:  Nutrients       Date:  2022-02-18       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.